Basis swap and AT1 impact Q1 2026

DNB Group will report a NOK 30m positive mark-to-market from basis swaps and a NOK 566m negative mark-to-market related to USD and SEK Additional Tier 1 capital in Q1 2026, resulting in a net negative impact of NOK 536m. Both items will be recorded under Net gains on financial instruments at fair value and will reduce reported Q1 fair-value gains.

Analysis

This is primarily an accounting-driven volatility event that will be interpreted as a liquidity/funding story by short-term traders even if the underlying solvency metrics remain intact. Mark-to-market moves on funding-related derivatives and hybrid capital tend to compress AT1 prices and widen implied bank-equity/credit volatility for several weeks after a disclosure; expect elevated flows into liquid hedges (equity puts, CDS) in the next 3–30 days.

Second-order winners will be instruments that sit senior to AT1 (senior unsecured and covered bonds) and banks with minimal FX-linked hybrid exposure; asset managers forced to de-risk AT1 allocations will likely rotate into those safer buckets, tightening spreads there within 1–3 months. Conversely, smaller regional issuers with concentrated FX exposures or large outstanding AT1 tranches face outsized repricing risk as buyers demand higher yields to compensate for perceived translation & basis volatility.

Key catalysts and tail risks are FX moves and regulatory optics: a sustained SEK depreciation or USD volatility can re-write quarterly P&L quickly, while a regulatory signal that treats these MTM losses as economically meaningful could force capital actions. Reversals come from one of three things — a technical rebound as AT1 buyers step in (days–weeks), a benign Q1 earnings pack and investor call where management frames losses as non-recurring (weeks), or FX stabilization (months).

The consensus will treat this as a headline hit and mark many AT1s and small-bank equities lower; that overstates permanent capital impairment risk and understates the likely reallocation into senior paper and covered bonds. Position for a two-phase move: initial knee-jerk widening (days) then selective normalization (weeks–months) as fundamentals reassert themselves.

Key Decisions for Investors

• Buy DNB equity (DNB.OL) on an intraday or 1–3% post-release gap down; target 6–10% mean-reversion over 1–3 months as AT1 technical selling abates. Risk: sector contagion could extend drawdown to 10–15%; set a protective stop at -6% from entry and size so a 10% shock is <2% portfolio.
• Initiate a relative-value pair: long DNB (DNB.OL) / short Nordea (NDA.ST) 3–9 month view — if market over-penalizes DNB’s accounting noise, expect 200–400bp outperformance vs peer within 3 months. Risk: macro-driven Nordic rally could lift both; keep net delta exposure neutral and cap pair notional so max P&L loss = 3% portfolio.
• Buy 1y CDS protection on select Swedish regional banks (e.g., SEB-A.ST, SHB-A.ST) as a cheap tail hedge — premium is small vs potential jump risk if AT1 repricing spreads contagion; asymmetric payoff if stress propagates. Risk: if no contagion, premium decays (cost of carry) — cap allocation to <0.5% portfolio per name.
• Go long 1–3 month implied volatility on AT1/hybrid instruments or buy deep-in-the-money put spreads on AT1 exchange-eligible issues (where available) to capture ongoing repricing risk while limiting premium spend. Target payoff 3x+ if AT1 curves reprice materially; risk limited to paid premium.